🔎 Trials Near Me

Home › Hereditary Sensory and Autonomic Neuropathies › Virginia

Pag-aaral pangklinika para sa Hereditary Sensory and Autonomic Neuropathies sa Virginia

7 pag-aaral para sa Hereditary Sensory and Autonomic Neuropathies ang naghahanap ng mga kalahok sa mga site sa Virginia.

Mga Lungsod sa Virginia

Opisyal na teksto ng pag-aaral (English)

Study of ACR-2316 in Specific Advanced Solid Tumors

  • Next Virginia, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06667141

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • USO-Virginia Cancer Specialists, PC, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NEXT, Fairfax
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

  • Virginia Cancer Specialists, Fairfax
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Abr 22, 2026 · NCT05683418

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

  • Virginia Cancer Specialists, P.C., Fairfax
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Dis 24, 2025 · NCT06463028

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.